Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 8/20 | 0.38 |
| ▸ | MTOR | P42345 | 5/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | ATR | Q13535 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 1/20 | 0.35 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2524376 | 0.90 | PRKDC (0.48) | PRKDCTP53PIK3CAMTORATM | |
| Trifluoroacetic Acid SCHEMBL6249083 | 0.84 | CTSS (0.45) | PARP1PARP2CTSSCRHR1 | |
| SCHEMBL3753459 | 0.78 | CYP3A4 (0.46) | PIK3CAMTORPARP1PARP2FEN1 | |
| SCHEMBL2251115 | 0.76 | TP53 (0.42) | PRKDCTP53 | |
| SCHEMBL3764320 | 0.75 | PIK3CA (0.51) | PRKDCPIK3CAMTOR | |
| SCHEMBL24478396 | 0.74 | TP53 (0.46) | PRKDCTP53PIK3CAMTORATM | |
| SCHEMBL29712755 | 0.74 | TP53 (0.46) | PRKDCTP53PIK3CAMTORATM | |
| Hydrochloric Acid SCHEMBL29241163 | 0.73 | TP53 (0.46) | PRKDCTP53PIK3CAMTORATM | |
| Hydrochloric Acid SCHEMBL30534118 | 0.73 | TP53 (0.46) | PRKDCTP53PIK3CAMTORATM | |
| SCHEMBL2254703 | 0.72 | OPRD1 (0.46) | PRKDCTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2249833-B1 | PRODRUGS OF CGRP RECEPTOR ANTAGONIST | MERCK SHARP & DOHME (US) | 2012-10-17 | — | — | EP | disclosed |
| US-8080544-B2 | Prodrugs of CGRP receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2011-12-20 | — | — | US | disclosed |
| US-20100298269-A1 | PRODRUGS OF CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298269-A1 | PRODRUGS OF CGRP RECEPTOR ANTAGONISTS | CALCRL, BDKRB1, BDKRB2 | PRKDC 4721/4885TP53 4540/4885GRIN1 326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.